Cure8 research brief
Patients diagnosed with IBD during or shortly after emergency hospital care had substantially worse 1-year outcomes in this large, population-based analysis — highlighting that late or emergency presentation is linked to poorer prognosis and greater hospital use.
People with IBD (especially newly diagnosed), clinicians and primary care teams, hospital specialists, health services researchers, and policy makers interested in diagnostic pathways and emergency care.
The study analysed linked primary care, hospital, and death records for 1.7 million patients with one of 13 conditions between 1999–2019. Emergency diagnosis rates were ≥20% for most conditions; for IBD the authors report a markedly increased adjusted odds ratio for 1-year mortality (example: adjusted OR 5.99 for men with IBD).
The authors adjusted for age, year, deprivation, comorbidity, and setting of diagnosis. Findings were consistent across data subsets and matched prior cancer studies, supporting method validity.
This paper does not provide interventions that prevent emergency diagnosis; instead it documents a pattern and calls for more research and investment to reduce emergency diagnoses, especially for conditions often expected to be identified in community care (including IBD).
The study is a broad, linked-record observational analysis (CPRD, HES, ONS) covering 1999–2019. It reports adjusted associations but cannot prove causation; results depend on accuracy of routine diagnostic coding and healthcare-record linkage.
Review the original publication for the complete reporting, methods, and context.
Conflict statement: I have read the journal’s policy and the authors of this manuscript have the following competing interests: HS reported consulting fees from The Leapfrog Group unrelated to this study. MEB reported consulting fees from Cancer Research UK and personal fees from GRAIL Inc. for Independent Data Monitoring Committee (IDMC) membership unrelated to this study. MR reported consulting fees from QIMR Berghofer Medical Research Institute unrelated to this study, honoraria from the Royal College of General Practitioners, support for attending meetings and/or travel from WHO Europe and is the co-chair of the Prevention and Early Diagnosis working group of the Primary Care Collaborative Cancer Clinical Trials Group funded by Cancer Australia. Unrelated to this study and the funding outlined in the Funding Statement, NZ is a Senior Data and Research Analyst at Cancer Research UK, and SD received funding in the past to co-create and co-lead the National Phenotype Library at HDR UK. All other authors have declared that no competing interests exist.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The study suggests most adults with chronic diarrhea in this tertiary setting had organic/inflammatory disease and identifies accessible clinical and lab predictors that could help prioritize endoscopic evaluation.
Patients with IBD receiving biologic therapy need regular lab monitoring, TB screening, vaccinations, and bone-density assessment; many of these services were underused before the dashboard. Tools that improve those...
This study highlights factors—tumor location, age, smoking, and having IBD—that were associated with survival and progression in a Lebanese CRC cohort.
